Literature DB >> 21931071

When should nitroglycerine be avoided in hypertensive encephalopathy?

Mohamed A Sheta, Madhu Paladugu, Joshua Mendelson, Neil R Holland.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2011        PMID： 21931071     DOI： 10.1161/HYPERTENSIONAHA.111.175703

Source DB:  PubMed          Journal:  Hypertension        ISSN： 0194-911X            Impact factor:   10.190


× No keyword cloud information.
  3 in total

Review 1.  Atypical presentation of posterior reversible encephalopathy syndrome: Clinical and radiological characteristics in eclamptic patients.

Authors:  Aleksandra Aracki-Trenkić; Dragan Stojanov; Milan Trenkić; Zoran Radovanović; Jelena Ignjatović; Saša Ristić; Marija Trenkić-Bozinović
Journal:  Bosn J Basic Med Sci       Date:  2016-06-20       Impact factor: 3.363

2.  Posterior Reversible Encephalopathy Syndrome Onset Within 24 Hours Following Moderna mRNA Booster COVID-19 Vaccination: Vaccine Adverse Event Vs. Hypertension?

Authors:  Jocelyn McCullough; Manal Ahmad; Idy Tam; Reid Portnoy; Joseph Ng; Kuschner Zachary; Alan Kaell
Journal:  Cureus       Date:  2022-05-11

Review 3.  Nitroglycerin Use in the Emergency Department: Current Perspectives.

Authors:  Michael J Twiner; John Hennessy; Rachel Wein; Phillip D Levy
Journal:  Open Access Emerg Med       Date:  2022-07-09
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.